S.983 - Breast Cancer and Environmental Research Act of 2003108th Congress (2003-2004)
|Sponsor:||Sen. Chafee, Lincoln [R-RI] (Introduced 05/01/2003)|
|Committees:||Senate - Health, Education, Labor, and Pensions|
|Latest Action:||Senate - 05/01/2003 Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (text of measure as introduced: CR S5674-5675) (All Actions)|
This bill has the status Introduced
Here are the steps for Status of Legislation:
Share This Section
Text: S.983 — 108th Congress (2003-2004)All Information (Except Text)
There is one version of the bill.
Text available as:
- PDF (PDF provides a complete and accurate display of this text.) Tip?
Introduced in Senate (05/01/2003)
[Congressional Bills 108th Congress] [From the U.S. Government Printing Office] [S. 983 Introduced in Senate (IS)] 108th CONGRESS 1st Session S. 983 To amend the Public Health Service Act to authorize the Director of the National Institute of Environmental Health Sciences to make grants for the development and operation of research centers regarding environmental factors that may be related to the etiology of breast cancer. _______________________________________________________________________ IN THE SENATE OF THE UNITED STATES May 1, 2003 Mr. Chafee (for himself, Mr. Reid, Mr. Hatch, Ms. Mikulski, Ms. Collins, Mr. Leahy, Mr. Warner, Mr. Kennedy, Mr. Voinovich, Mr. Biden, Mr. Allen, Mrs. Clinton, Mr. Fitzgerald, Mrs. Murray, Ms. Snowe, Mr. Johnson, Mr. Feingold, Mrs. Feinstein, Mr. Reed, and Mr. Corzine) introduced the following bill; which was read twice and referred to the Committee on Health, Education, Labor, and Pensions _______________________________________________________________________ A BILL To amend the Public Health Service Act to authorize the Director of the National Institute of Environmental Health Sciences to make grants for the development and operation of research centers regarding environmental factors that may be related to the etiology of breast cancer. Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, SECTION 1. SHORT TITLE. This Act may be cited as the ``Breast Cancer and Environmental Research Act of 2003''. SEC. 2. FINDINGS. The Congress finds as follows: (1) Breast cancer is the second leading cause of cancer deaths among American women. (2) More women in the United States are living with breast cancer than any other cancer (excluding skin cancer). Approximately 3,000,000 women in the United States are living with breast cancer, 2,000,000 of which have been diagnosed and an estimated 1,000,000 who do not yet know that they have the disease. (3) Breast cancer is the most commonly diagnosed cancer among women in the United States and worldwide (excluding skin cancer). In 2003, it is estimated that 258,600 new cases of breast cancer will be diagnosed among women in the United States, 211,300 cases of which will involve invasive breast cancer and 47,300 cases of which will involve ductal carcinoma in situ (DCIS). (4) Breast cancer is the second leading cause of cancer death for women in the United States. Approximately 40,000 women in the United States die from the disease each year. Breast cancer is the leading cause of cancer death for women in the United States between the ages of 20 and 59, and the leading cause of cancer death for women worldwide. (5) A woman in the United States has a 1 in 8 chance of developing invasive breast cancer in her lifetime. This risk was 1 in 11 in 1975. In 2001, a new case of breast cancer will be diagnosed every 2 minutes and a woman will die from breast cancer every 13 minutes. (6) All women are at risk for breast cancer. About 90 percent of women who develop breast cancer do not have a family history of the disease. (7) The National Action Plan on Breast Cancer, a public private partnership, has recognized the importance of expanding the scope and breadth of biomedical, epidemiological, and behavioral research activities related to the etiology of breast cancer and the role of the environment. (8) To date, there has been only a limited research investment to expand the scope or coordinate efforts across disciplines or work with the community to study the role of the environment in the development of breast cancer. (9) In order to take full advantage of the tremendous potential for avenues of prevention, the Federal investment in the role of the environment and the development of breast cancer should be expanded. (10) In order to understand the effect of chemicals and radiation on the development of cancer, multi-generational, prospective studies are probably required. SEC. 3. NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES; AWARDS FOR DEVELOPMENT AND OPERATION OF RESEARCH CENTERS REGARDING ENVIRONMENTAL FACTORS RELATED TO BREAST CANCER. Subpart 12 of part C of title IV of the Public Health Service Act (42 U.S.C. 285l et seq.) is amended by adding at the end the following section: ``SEC. 463B. RESEARCH CENTERS REGARDING ENVIRONMENTAL FACTORS RELATED TO BREAST CANCER. ``(a) In General.--The Director of the Institute, based on recommendations from the Breast Cancer and Environmental Research Panel established under subsection (b) (referred to in this section as the `Panel') shall make grants, after a process of peer review and programmatic review, to public or nonprofit private entities for the development and operation of not more than 8 centers for the purpose of conducting multidisciplinary and multi-institutional research on environmental factors that may be related to the etiology of breast cancer. Each such center shall be known as a Breast Cancer and Environmental Research Center of Excellence. ``(b) Breast Cancer and Environmental Research Panel.-- ``(1) Establishment.--The Secretary shall establish in the Institute of Environmental Health Sciences a Breast Cancer and Environmental Research Panel. ``(2) Composition.--The Panel shall be composed of-- ``(A) 9 members to be appointed by the Secretary, of which-- ``(i) six members shall be appointed from among physicians, and other health professionals, who-- ``(I) are not officers or employees of the United States; ``(II) represent multiple disciplines, including clinical, basic, and public health sciences; ``(III) represent different geographical regions of the United States; ``(IV) are from practice settings or academia or other research settings; and ``(V) are experienced in biomedical review; and ``(ii) three members shall be appointed from the general public who are representatives of individuals who have had breast cancer and who represent a constituency; and ``(B) such nonvoting, ex officio members as the Secretary determines to be appropriate. ``(3) Chairperson.--The members of the Panel appointed under paragraph (2)(A) shall select a chairperson from among such members. ``(4) Meetings.--The Panel shall meet at the call of the chairperson or upon the request of the Director, but in no case less often than once each year. ``(5) Duties.--The Panel shall-- ``(A) oversee the peer review process for the awarding of grants under subsection (a) and conduct the programmatic review under such subsection; ``(B) make recommendations with respect to the funding criteria and mechanisms under which amounts will be allocated under this section; and ``(C) make final programmatic recommendations with respect to grants under this section. ``(c) Collaboration With Community.--Each center under subsection (a) shall establish and maintain ongoing collaborations with community organizations in the geographic area served by the center, including those that represent women with breast cancer. ``(d) Coordination of Centers; Reports.--The Director of the Institute shall, as appropriate, provide for the coordination of information among centers under subsection (a) and ensure regular communication between such centers, and may require the periodic preparation of reports on the activities of the centers and the submission of the reports to the Director. ``(e) Required Consortium.--Each center under subsection (a) shall be formed from a consortium of cooperating institutions, meeting such requirements as may be prescribed by the Director of the Institute. Each center shall require collaboration among highly accomplished scientists, other health professionals and advocates of diverse backgrounds from various areas of expertise. ``(f) Duration of Support.--Support of a center under subsection (a) may be for a period not exceeding 5 years. Such period may be extended for one or more additional periods not exceeding 5 years if the operations of such center have been reviewed by an appropriate technical and scientific peer review group established by the Director of the Institute and if such group has recommended to the Director that such period should be extended. ``(g) Geographic Distribution of Centers.--The Director of the Institute shall, to the extent practicable, provide for an equitable geographical distribution of centers under this section. ``(h) Innovative Approaches.--Each center under subsection (a) shall use innovative approaches to study unexplored or under-explored areas of the environment and breast cancer. ``(i) Authorization of Appropriations.--For the purpose of carrying out this section, there is authorized to be appropriated $30,000,000 for each of the fiscal years 2004 through 2009. Such authorization is in addition to any other authorization of appropriations that is available for such purpose.''. <all>